ClinicalTrials.Veeva

Menu

Etiology, Epidemiology and Prognostics of AKI

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Enrolling

Conditions

Acute Kidney Injury

Study type

Observational

Funder types

Other

Identifiers

NCT02967263
AKI-2016-01

Details and patient eligibility

About

  • To investigate the etiology and epidemiology of acute kidney injury (AKI).
  • To find out risk factors associated with the occurence of AKI.
  • To find out risk factors related to the prognosis of AKI,focusing on uremic toxins, inflammation, oxidative stress and nutritional status.
  • To study on the relationship between gene polymorphism and prognosis of acute kidney injury.

Full description

  1. To investigate the relationship between preexisting protein-energy wasting (PEW) and adverse outcomes in patients with AKI.
  2. To evaluate the association of serum nutritional variables and prognosis of AKI.
  3. Given the different half-lives of serum nutritional markers, we hypothesized that the utility of serum nutritional variables as prognostic predictors may differ in early death (<7 days) and late death (>7 days, <28 days) patients.
  4. To investigate the various kinds of uremic toxins in AKI, furthermore, to evaluate the relationship between uremic toxins, especially protein bound toxins, and short- or long-term mortality in AKI patients.
  5. To investigate the mineral bone disorders in AKI,and to evaluate whether these markers would role as prognostic predictors of AKI.
  6. Several risk factors of mortality in AKI,such as markers of PEW, inflammation and serum creatinine,have been used; however, no single indicator is considered to be a "gold standard."

Enrollment

713 estimated patients

Sex

All

Ages

18 to 89 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age >=18 years and <= 88 years
  • clinically diagnosed with acute kidney injury, according KDIGO criteria.

Exclusion criteria

  • preexisting chronic kidney failure (defined as an eGFR <60 ml/min per 1.73 m2)
  • post-renal obstruction or rapid progressive glomerulonephritis as the main cause of AKI
  • known acute renal dysfunction
  • hospital stays <24 hours
  • malignancy

Trial design

713 participants in 1 patient group

Hospital-acquired AKI
Description:
Adult patients with Hospital-acquired AKI

Trial contacts and locations

1

Loading...

Central trial contact

Feng Ding, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems